Subscribe To
Algernon pharma receives notice of allowance from us patent and trademark office for repirinast
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has received a Notice of Allowance from th...
April 17, 2023, 8:16 am
Empower clinics signs clinical trials services deal with texas medical group
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced an agreement to develop a program for research and clinical trials services with a Dallas, T...
April 17, 2023, 7:47 am
Amneal pharmaceuticals' stock soars 14% premarket after company offers upbeat q1 guidance
Amneal pharmaceuticals Inc.'s stock AMRX, -2.16% soared 14% in premarket trade Monday, after the generi...
April 17, 2023, 6:53 am
Snbl to acquire satsuma pharmaceuticals
Transaction delivers immediate value and liquidity to Satsuma stockholders SNBL to acquire all outstanding shares of Satsuma for upfront cash consider...
April 16, 2023, 11:41 pm
Is arrowhead pharmaceuticals a buy now?
Arrowhead pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that...
April 16, 2023, 5:21 am
Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting, will host webinar
Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody,...
April 16, 2023, 3:01 am
1 "safe" stock to avoid and 1 to consider buying in april
In theory, the stock of companies that make generic drugs have the potential to be safe investments. Despite that, companies like Teva ...
April 15, 2023, 8:56 am
Does an fda fast track designation make regenxbio stock a buy now?
RegenxBio has several collaborations with other pharmaceutical companies. The company doesn't have its ...
April 15, 2023, 8:20 am
Abbvie: an investor's trifecta in transition
AbbVie is a pharmaceutical giant that is building out its portfolio to look nothing like it did a decad...
April 15, 2023, 7:35 am
Phathom pharmaceuticals, inc: company investigated by the portnoy law firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) — The Portnoy...
April 14, 2023, 10:37 pm
Us charges el chapo sons, chinese businessmen with fentanyl trafficking
By Katharine Jackson and Luc Cohen (Reuters) – The United States has charged leaders of the Mexico-based Sinaloa Cartel with running a fentanyl traf...
April 14, 2023, 4:46 pm
Teva to host conference call to discuss first quarter 2023 financial results at 8 a.m. et on may 10, 2023
TEL AVIV, Israel--(BUSINESS WIRE)--Teva pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced ...
April 14, 2023, 4:15 pm
Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session
– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhibitors with potent anti-tumor a...
April 14, 2023, 4:05 pm
Ocular therapeutix™ to present pre-clinical and clinical data at the 2023 association for research in vision and ophthalmology (arvo) annual meeting
BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical...
April 14, 2023, 4:01 pm
Theratechnologies stock price continues higher on company guidance
Theratechnologies (TSX:TH) Inc shares continued to advance Friday, up 12% to $1.29 following a 10% gain on Thursday, after the bio...
April 14, 2023, 2:33 pm
Aadi bioscience to present multiple posters on nab-sirolimus at the 2023 american association for cancer research (aacr) annual meeting
LOS ANGELES , April 14, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharm...
April 14, 2023, 1:09 pm
Amyotrophic lateral sclerosis treatment market sales to reach us$ 1021 million in 2032 | cagr of 5.6%
Investment in research and development by pharmaceutical companies is expected to propel the growth of ...
April 14, 2023, 12:50 pm
Global methenamine hippurate tablets market size is anticipated to acquire 6.51% billion by 2030 with cagr of 6.51% | pharmaceuticals industry analysis
[214 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Methenamine Hippura...
April 14, 2023, 12:06 pm
Spero therapeutics to present data at the 33rd european congress of clinical microbiology and infectious diseases
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage bio...
April 14, 2023, 12:05 pm
Achieve life sciences to present at life science innovation northwest 2023 conference
SEATTLE and VANCOUVER, British Columbia, April 14, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage ...
April 14, 2023, 12:00 pm